HK1181998A1 - Pharmaceutical emulsion compositions comprising progestogen - Google Patents

Pharmaceutical emulsion compositions comprising progestogen

Info

Publication number
HK1181998A1
HK1181998A1 HK13109274.3A HK13109274A HK1181998A1 HK 1181998 A1 HK1181998 A1 HK 1181998A1 HK 13109274 A HK13109274 A HK 13109274A HK 1181998 A1 HK1181998 A1 HK 1181998A1
Authority
HK
Hong Kong
Prior art keywords
progestogen
emulsion compositions
pharmaceutical emulsion
pharmaceutical
compositions
Prior art date
Application number
HK13109274.3A
Other languages
English (en)
Chinese (zh)
Inventor
Laura Pickersgill
Eva-Maria Di Hoiser
Georg Achleitner
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Publication of HK1181998A1 publication Critical patent/HK1181998A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HK13109274.3A 2010-04-26 2013-08-08 Pharmaceutical emulsion compositions comprising progestogen HK1181998A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US32796810P 2010-04-26 2010-04-26
US32795910P 2010-04-26 2010-04-26
US32796310P 2010-04-26 2010-04-26
EP10161029 2010-04-26
EP10161034 2010-04-26
EP10161032 2010-04-26
US201061424407P 2010-12-17 2010-12-17
US201061424402P 2010-12-17 2010-12-17
US201061424411P 2010-12-17 2010-12-17
EP10195766 2010-12-17
EP10195760 2010-12-17
EP10195764 2010-12-17
PCT/EP2011/056539 WO2011134937A2 (fr) 2010-04-26 2011-04-26 Compositions d'émulsion pharmaceutique comprenant du progestogène

Publications (1)

Publication Number Publication Date
HK1181998A1 true HK1181998A1 (en) 2013-11-22

Family

ID=44001967

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13109274.3A HK1181998A1 (en) 2010-04-26 2013-08-08 Pharmaceutical emulsion compositions comprising progestogen

Country Status (22)

Country Link
US (4) US8476252B2 (fr)
EP (4) EP2857042B1 (fr)
JP (1) JP5886273B2 (fr)
KR (1) KR101822680B1 (fr)
CN (2) CN102946864A (fr)
AR (1) AR081542A1 (fr)
AU (1) AU2011246527B2 (fr)
BR (1) BR112012027279B1 (fr)
CA (2) CA2797253C (fr)
EA (1) EA022460B1 (fr)
ES (4) ES2514690T3 (fr)
GE (1) GEP20166457B (fr)
HK (1) HK1181998A1 (fr)
IL (2) IL222710A (fr)
MX (1) MX2012012491A (fr)
MY (1) MY156858A (fr)
NZ (1) NZ603176A (fr)
PL (1) PL2563335T3 (fr)
PT (1) PT2563335E (fr)
SG (1) SG185025A1 (fr)
TW (1) TW201138782A (fr)
WO (2) WO2011134944A2 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2819650A1 (fr) 2012-02-29 2015-01-07 B. Braun Melsungen AG Émulsion contenant des hormones comprenant des phospholipides de krill
TW201334808A (zh) * 2012-02-29 2013-09-01 Braun Melsungen Ag 含有荷爾蒙之包含磷蝦磷脂質的乳劑
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014145303A1 (fr) * 2013-03-15 2014-09-18 Pharmagenesis, Inc. Émulsions intraveineuses de triptolide comme immunomodulateurs et agents anticancéreux
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
US11725237B2 (en) 2013-12-05 2023-08-15 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
EP4052724A1 (fr) * 2013-12-06 2022-09-07 The Broad Institute Inc. Formulations des vaccins contre la néoplasie
KR20160101073A (ko) 2013-12-20 2016-08-24 더 브로드 인스티튜트, 인코퍼레이티드 신생항원 백신과의 병용 요법
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112016029338A2 (pt) 2014-07-29 2017-08-22 Therapeuticsmd Inc creme transdérmico
WO2016100975A1 (fr) 2014-12-19 2016-06-23 Massachsetts Institute Ot Technology Biomarqueurs moléculaires pour l'immunothérapie d'un cancer
WO2016100977A1 (fr) 2014-12-19 2016-06-23 The Broad Institute Inc. Procédés pour le profilage du répertoire de récepteurs de cellules t
JP6814148B2 (ja) * 2015-03-31 2021-01-13 フレゼニウス カービ ドイチュラント ゲーエムベーハー 非経口投与用のエマルション
CN116196401A (zh) 2015-05-20 2023-06-02 博德研究所 共有的新抗原
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone steroide
CN106074383B (zh) * 2016-07-27 2019-03-08 武汉科福新药有限责任公司 孕激素药物脂微球注射液及其制备方法
US20180207177A1 (en) * 2017-01-23 2018-07-26 Government Of The United States As Represented By The Secretary Of The Air Force TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2)
US11549149B2 (en) 2017-01-24 2023-01-10 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
KR20210102936A (ko) * 2018-12-10 2021-08-20 헤일로 사이언스 엘엘씨 안정적인 마취제 제제 및 관련 복용량 형태
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3878434A1 (fr) * 2020-03-12 2021-09-15 Lipoid GmbH Composition de phospholipides de tournesol contenant de la phosphatidylcholine
US20230098327A1 (en) * 2021-08-30 2023-03-30 Premier Nutrition Company, Llc Sleep-inducing beverage composition, its method of production and the method of use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258110A (ja) 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
IL89856A (en) 1989-04-05 1993-05-13 Yissum Res Dev Co Medical emulsions for liphophilic drugs containing a medium-chain triglyceride oil as a carrier
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
WO2001007086A1 (fr) * 1999-07-22 2001-02-01 Aventis Pharmaceuticals, Inc. Formulations pharmaceutiques contenant des agents de conservation
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6327968B1 (en) 2000-03-17 2001-12-11 Pizza Hut, Inc. System and method for producing par-baked pizza crusts
EP1488785A1 (fr) 2003-06-18 2004-12-22 B. Braun Melsungen Ag Emulsion à l'huile pour la substitution postnatale des hormones
WO2005105040A2 (fr) 2004-04-26 2005-11-10 Micelle Products, Inc. Preparation hydrosoluble de vitamines liposolubles, agents pharmaceutiques et leurs applications
DE602004022523D1 (de) 2004-07-02 2009-09-24 Novagali Pharma Sa Verwendung von Emulsionen zur intra- und periocularen Injection
US7473687B2 (en) 2005-03-24 2009-01-06 Emory University Methods for the treatment of a traumatic central nervous system injury
ES2428313T3 (es) 2005-03-24 2013-11-07 Emory University Métodos para el tratamiento de lesiones del sistema nervioso central mediante un protocolo de administración decreciente
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
CN101152186B (zh) * 2007-09-05 2011-07-06 杭州平和安康医药科技有限公司 黄体酮注射液及其制备方法
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen

Also Published As

Publication number Publication date
PT2563335E (pt) 2015-03-31
US8765149B2 (en) 2014-07-01
WO2011134944A3 (fr) 2012-02-09
CA2797141C (fr) 2018-05-15
BR112012027279B1 (pt) 2020-12-29
AU2011246527A1 (en) 2012-11-15
ES2576190T3 (es) 2016-07-06
IL222738A (en) 2015-11-30
AR081542A1 (es) 2012-10-03
IL222710A (en) 2015-11-30
NZ603176A (en) 2014-05-30
IL222738A0 (en) 2012-12-31
TW201138782A (en) 2011-11-16
EP2563334B1 (fr) 2014-07-16
ES2606585T3 (es) 2017-03-24
BR112012027279A2 (pt) 2018-05-15
EA022460B1 (ru) 2016-01-29
CA2797141A1 (fr) 2011-11-03
EP2563334A2 (fr) 2013-03-06
EP2563335B1 (fr) 2014-12-17
WO2011134944A2 (fr) 2011-11-03
CA2797253A1 (fr) 2011-11-03
SG185025A1 (en) 2012-11-29
IL222710A0 (en) 2012-12-31
EP2801353A1 (fr) 2014-11-12
CN102946865B (zh) 2016-06-22
EP2857042A1 (fr) 2015-04-08
EP2563335A2 (fr) 2013-03-06
EP2801353B1 (fr) 2016-03-30
CN102946865A (zh) 2013-02-27
US20110262494A1 (en) 2011-10-27
EA201291108A1 (ru) 2013-04-30
CN102946864A (zh) 2013-02-27
US9572818B2 (en) 2017-02-21
GEP20166457B (en) 2016-04-11
JP2013525402A (ja) 2013-06-20
US20110262495A1 (en) 2011-10-27
EP2857042B1 (fr) 2016-08-31
WO2011134937A2 (fr) 2011-11-03
ES2514690T3 (es) 2014-10-28
US8476252B2 (en) 2013-07-02
MY156858A (en) 2016-04-15
US20140335133A1 (en) 2014-11-13
ES2531646T3 (es) 2015-03-18
MX2012012491A (es) 2013-02-15
WO2011134937A3 (fr) 2012-02-02
PL2563335T3 (pl) 2015-05-29
CA2797253C (fr) 2019-02-05
JP5886273B2 (ja) 2016-03-16
US20140147474A1 (en) 2014-05-29
KR20130069638A (ko) 2013-06-26
KR101822680B1 (ko) 2018-01-26
AU2011246527B2 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
IL298436B2 (en) Pharmaceutical preparations that include allopregnanolone
HK1181998A1 (en) Pharmaceutical emulsion compositions comprising progestogen
ZA201300458B (en) C-met-modulator pharmaceutical compositions
IL223535A (en) Solid medicinal compositions
ZA201301766B (en) Pharmaceutical compositions
ZA201300718B (en) Pharmaceutical compositions
ZA201207670B (en) Pharmaceutical compositions
ZA201303223B (en) Pharmaceutical compositions
IL226554A (en) Medicinal preparations containing alisporiovir
ZA201303177B (en) Pharmaceutical compositions
IL221501A (en) Medicinal product containing miramistine
GB201001911D0 (en) Pharmaceutical composition
EP2560678A4 (fr) Compositions pharmaceutiques
HK1200328A1 (zh) 含有孕激素的低油藥用乳液組合物
ZA201303732B (en) Pharmaceutical compositions
GB201008590D0 (en) Pharmaceutical compositions
GB201005403D0 (en) Novel pharmaceutical compositions